Home/Filings/4/0000950170-25-063063
4//SEC Filing

Duarte Ira 4

Accession 0000950170-25-063063

CIK 0000818033other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 8:32 PM ET

Size

6.9 KB

Accession

0000950170-25-063063

Insider Transaction Report

Form 4
Period: 2025-04-30
Duarte Ira
EVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-04-30+11,694175,416 total
    Exercise: $0.00Common Stock (11,694 underlying)
  • Exercise/Conversion

    Common Stock

    2025-04-30+11,694136,149 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001488864

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 8:32 PM ET
Size
6.9 KB